HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio C Bianco Selected Research

Triiodothyronine (Liothyronine)

1/2022Extended Absorption of Liothyronine from Poly-Zinc-Liothyronine: Results from a Phase 1, Double-Blind, Randomized, and Controlled Study in Humans.
3/2021Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
1/2021Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
10/2020Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism.
1/2020Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?
11/2014Defending plasma T3 is a biological priority.
7/2012Thyroid hormone replacement therapy: three 'simple' questions, complex answers.
4/2007Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats.
3/2004Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis.
1/2003Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio C Bianco Research Topics

Disease

48Hypothyroidism
03/2022 - 01/2002
16Obesity
01/2019 - 04/2005
7Fatty Liver
01/2019 - 09/2009
6Body Weight (Weight, Body)
01/2016 - 04/2007
4Glucose Intolerance
08/2014 - 11/2009
4Insulin Resistance
11/2009 - 06/2005
3Neoplasms (Cancer)
01/2022 - 04/2005
3Critical Illness (Critically Ill)
01/2020 - 03/2008
3Thyrotoxicosis
01/2019 - 11/2003
3Infections
12/2015 - 09/2005
3Hypoxia (Hypoxemia)
06/2012 - 03/2008
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 01/2018
2Fibrosis (Cirrhosis)
01/2018 - 05/2012
2Thyroid Diseases (Thyroid Disease)
11/2014 - 01/2014
2Hyperglycemia
06/2014 - 11/2009
2Heart Failure
05/2012 - 03/2008
2Weight Loss (Weight Reduction)
11/2011 - 09/2009
2Type 2 Diabetes Mellitus (MODY)
09/2009 - 06/2005
1Mental Fatigue
03/2022
1COVID-19
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Thyroid Neoplasms (Thyroid Cancer)
01/2022
1Acute Lung Injury
01/2022
1Osteoarthritis
01/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Abnormal Thyroid Hormone Metabolism
01/2021
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2020
1Hyperthyroidism
01/2019
1Hypertriglyceridemia
01/2019
1Atrial Fibrillation
01/2019
1Cardiac Arrhythmias (Arrythmia)
01/2019
1Thyroid Crisis (Thyrotoxic Crisis)
01/2019
1Myxedema
01/2019
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2018
1Idiopathic Pulmonary Fibrosis
01/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2017
1Aortic Valve Stenosis (Aortic Stenosis)
01/2017
1Myocardial Stunning (Stunned Myocardium)
01/2017
1Right Ventricular Hypertrophy
01/2017
1Glioma (Gliomas)
06/2015
1Bone Resorption
04/2015
1Mitochondrial Diseases (Mitochondrial Disease)
03/2015
1Inflammation (Inflammations)
03/2015
1Central Nervous System Diseases (CNS Diseases)
03/2015
1Hyperlipidemias (Hyperlipidemia)
06/2014
1Hyperinsulinism (Hyperinsulinemia)
06/2014
1Hemorrhage
10/2013

Drug/Important Bio-Agent (IBA)

37Thyroid HormonesIBA
03/2022 - 10/2002
26Thyroxine (Levothyroxine)FDA LinkGeneric
01/2022 - 01/2003
23Iodide Peroxidase (Deiodinase)IBA
01/2022 - 03/2005
10Messenger RNA (mRNA)IBA
01/2022 - 10/2002
10Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2022 - 01/2003
6Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2022 - 04/2005
6CholesterolIBA
01/2020 - 04/2005
6Glucose (Dextrose)FDA LinkGeneric
12/2016 - 11/2009
4Thyroid (USP)IBA
01/2022 - 01/2020
4EnzymesIBA
01/2018 - 06/2005
3LipidsIBA
01/2018 - 09/2009
3Triglycerides (Triacylglycerol)IBA
01/2018 - 11/2009
3Iodothyronine Deiodinase Type IIIBA
05/2010 - 03/2004
2Pharmaceutical PreparationsIBA
01/2021 - 11/2011
2Amiodarone (Amiodarona)FDA LinkGeneric
01/2019 - 02/2002
2GC 1 compoundIBA
01/2018 - 04/2007
2Adrenergic Agents (Adrenergic Drugs)IBA
12/2016 - 07/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2015 - 12/2008
2Insulin (Novolin)FDA Link
06/2014 - 01/2006
2Fatty Acids (Saturated Fatty Acids)IBA
05/2014 - 05/2007
2Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
06/2012 - 05/2010
2Proteins (Proteins, Gene)FDA Link
06/2012 - 03/2008
2Thyroid Hormone Receptors beta (TR beta)IBA
05/2010 - 11/2003
2Protein Isoforms (Isoforms)IBA
05/2010 - 11/2003
2Bile Acids and Salts (Bile Acids)IBA
09/2009 - 12/2008
2NF-kappa B (NF-kB)IBA
12/2008 - 09/2006
1selpercatinibIBA
01/2022
1pralsetinibIBA
01/2022
117-hydroxyestrane-3-carbonitrile (ECN)IBA
01/2020
1Ethanol (Ethyl Alcohol)IBA
01/2019
1VLDL LipoproteinsIBA
01/2019
1Ferritins (Ferritin)IBA
08/2018
1Sex Hormone-Binding GlobulinIBA
08/2018
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2018
1Biomarkers (Surrogate Marker)IBA
08/2018
1oxidized low density lipoproteinIBA
08/2018
1Creatine Kinase (Creatine Phosphokinase)IBA
08/2018
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2018
1Iopanoic Acid (Telepaque)FDA Link
01/2016
1Propranolol (Inderal)FDA LinkGeneric
01/2016
15- amino- 7- (cyclohexylamino)- 1- ethyl- 6- fluoro- 4- oxo- 1,4- dihydroquinoline- 3- carboxylic acidIBA
12/2015
1Thyrotropin-Releasing Hormone (Protirelin)FDA Link
10/2015
1hydroxide ionIBA
06/2015
12,2',4,4',5-brominated diphenyl etherIBA
06/2015
16-OH-BDE-47IBA
06/2015
1Halogenated Diphenyl EthersIBA
06/2015
1glutathione-independent formaldehyde dehydrogenase (formaldehyde dehydrogenase)IBA
04/2015
1Mitochondrial Proteins (Mitochondrial Protein)IBA
03/2015
1UbiquitinIBA
03/2015

Therapy/Procedure

10Therapeutics
03/2022 - 02/2002
1Duration of Therapy
01/2018
1Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2017
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2017